DESAI VEERAL (Chief Strategy & Dev. Officer) received a stock award from AGILON HEALTH, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 4/20/2022ACC: 0001209191-22-025009
Officer· Chief Strategy & Dev. Officer
Since Apr 2021
+69.75K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
69.75K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+16.25K
Price / share
—
Trade value
—
% of position
6.2%
4/14/2022
261.96K→278.21K
Total
Net shares
+16.25K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/14/2022 | A · Award | +16.25K | — | — | 6.2% | 261.96K | 278.21K |
| Total | +16.25K | $0.00 | ||||||
Derivative Transactions1
Options (Rights to Buy)
Direct
Converts to
Common Stock
53.50K shares
Shares
+53.50K
Strike price
23.07
Held after
53.50K
Exercisable
—
4/14/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Options (Rights to Buy) Direct | Common Stock53.50K shares | 4/14/2022 | A · Award | +53.50K | 23.07 | — | 53.50K |